JP Patent

JP7390487B2 — 焦点接着キナーゼ阻害剤としての新規なアダマンタン誘導体

Assigned to サムジン ファーマシューティカル カンパニー，リミテッド · Expires 2023-12-01 · 2y expired

What this patent protects

Patent listed against Zykadia.

Drugs covered by this patent

Patent Metadata

Patent number
JP7390487B2
Jurisdiction
JP
Classification
—
Expires
2023-12-01
Drug substance claim
No
Drug product claim
No
Assignee
サムジン ファーマシューティカル カンパニー，リミテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.